[EXHIBIT 8(ff)]
PARTICIPATION AGREEMENT
AMONG
▇▇▇▇▇▇▇ ▇▇▇▇▇ LIFE INSURANCE COMPANY,
[_____________________________________________], AND
[__________________________]
THIS AGREEMENT, dated as of the _____ day of _________, 200_, by and among
▇▇▇▇▇▇▇ ▇▇▇▇▇ Life Insurance Company (the "Company"), an Arkansas life insurance
company, on its own behalf and on behalf of each segregated asset account of the
Company set forth on Schedule A hereto as may be amended from time to time
(hereinafter referred to individually and collectively as the "Account"), each
of the trusts and the corporation listed on Schedule B (each a "Fund" and
collectively the "Funds"), and JPMorgan Distribution Services, Inc. (the
"Underwriter"), a Delaware company.
WHEREAS, the shares of beneficial interests of the Fund are divided into
several series of shares, each designated a "Portfolio" and representing the
interest in a particular managed portfolio of securities and other assets;
WHEREAS, the Fund is registered as an open-end management investment
company under the Investment Company Act of 1940, as amended, (the "1940 Act")
and shares of the Portfolios are registered under the Securities Act of 1933, as
amended (the "1933 Act");
WHEREAS, JPMorgan Investment Advisers, Inc. and ▇.▇. ▇▇▇▇▇▇ Investment
Management Inc. (the "Adviser"), each a _______________ [company], each of which
serves as investment adviser to various of the Portfolios, are each duly
registered as an investment adviser under the Investment Advisers Act of 1940,
as amended;
WHEREAS, the Underwriter, which serves as distributor to the Fund, is
registered as a broker-dealer with the Securities and Exchange Commission (the
"SEC") under the Securities Exchange Act of 1934, as amended (the "1934 Act"),
and is a member in good standing of the National Association of Securities
Dealers, Inc. (the "NASD");
WHEREAS, the Account is duly established and maintained as a segregated
asset account, duly established by the Company, on the date shown for such
Account on Schedule A hereto, to set aside and invest assets attributable to
variable annuity contracts set forth in Schedule A hereto, as it may be amended
from time to time by mutual written agreement (the "Contracts");
WHEREAS, each [Portfolio] issues shares to the general public and pursuant
to this Agreement, will issue shares to the separate accounts of insurance
companies ("Participating
1
Insurance Companies") to fund variable annuity contracts sold to certain
qualified pension and retirement plans;
WHEREAS, the Company intends to purchase shares of other open-end
management investment companies that offer shares to the general public to fund
the Contracts;
WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase shares in the [Portfolios] (and
classes thereof) listed in Schedule B hereto, as it may be amended from time to
time by mutual written agreement (the "Designated Portfolios") on behalf of the
Account to fund the aforesaid Contracts, and the Underwriter is authorized to
sell such shares in the Designated Portfolios, and classes thereof, to the
Account at net asset value.
NOW, THEREFORE, in consideration of their mutual promises, the Company,
the Fund, and the Underwriter agree as follows:
ARTICLE I. Sale of Fund Shares
1.1. The Fund has granted to the Underwriter exclusive authority to
distribute the Fund's shares, and pursuant to a written agreement between the
Fund and the Underwriter, the Underwriter is authorized to make available to the
Company for purchase on behalf of the Account shares [of the Designated
Portfolios] and classes thereof listed on Schedule B to this Agreement (the
"Shares"). Pursuant to such authority and instructions, and subject to Article
IX hereof, the Underwriter agrees to make the Shares available to the Company
for purchase on behalf of the Account, such purchases to be effected at net
asset value in accordance with Section 1.3 of this Agreement. Notwithstanding
the foregoing, the Board of Directors of the Fund (the "Board") may suspend or
terminate the offering of Shares of any Designated Portfolio or class thereof.
In addition, the Underwriter and the Fund reserve the right to reject any
purchase order in their sole discretion.
1.2. The Fund shall redeem, at the Company's request, any full or
fractional Shares held by the Company on behalf of the Account, such redemptions
to be effected at net asset value in accordance with Section 1.3 of this
Agreement. Notwithstanding the foregoing, (i) the Company shall not redeem
Shares attributable to Contract owners except in the circumstances permitted in
Section 9.3 of this Agreement, and (ii) the Fund may delay redemption of Shares
of any Designated Portfolio to the extent permitted by the 1940 Act, and any
rules, regulations, or orders thereunder.
1.3. Purchase and Redemption Procedures
The Fund hereby appoints the Company as an agent of the Fund for the limited
purpose of receiving purchase and redemption requests on behalf of the Account
(but not with respect to any Fund shares
2
that may be held in the general account of the Company) for the Shares made
available hereunder, based on allocations of amounts to the Account or
subaccounts thereof under the Contracts and other transactions relating to the
Contracts or the Account. All transactions in Account shares shall be executed
through the Omnibus Accounts Company's affiliate ▇▇▇▇▇▇▇ Lynch, Pierce, ▇▇▇▇▇▇ &
▇▇▇▇▇, Inc. maintains with the Designated Portfolios ("Omnibus Accounts").
Receipt of any such request (or relevant transactional information therefor) on
any day the New York Stock Exchange is open for trading and on which the Fund
calculates its net asset value pursuant to the rules of the SEC (a "Business
Day") by the Company as such limited agent of the Fund prior to the time that
the Fund ordinarily calculates its net asset value as described from time to
time in the applicable current fund prospectus (the "Prospectus") (which as of
the date of execution of this Agreement is 4:00 p.m. Eastern Time) shall
constitute receipt by the Fund on that same Business Day, provided that the
Underwriter receives notice of such request by 10 a.m. Eastern Time on the next
following Business Day, or in the event of systems issues necessitating later
delivery of such purchase and redemption requests by 11 a.m. Eastern Time on the
next following Business Day. Company and Underwriter understand that it is the
intent of the parties that Fund receive such purchase and redemption requests
from Company on behalf of the Account by 9:00 a.m. Eastern Time on the next
following Business Day. Company will provide to the Transfer Agent or its
designee via the NSCC Fund SERV DCC & S platform (which utilizes the "as of"
record layout within Fund/SERV) one or more files detailing the instructions
received by the Company with respect to each Plan prior to 4:00 p.m. Eastern
Time on the prior Business Day for each of the Funds. If for any reason ▇▇▇▇▇▇▇
▇▇▇▇▇ is unable to transmit the file(s) with respect to any Business Day,
▇▇▇▇▇▇▇ ▇▇▇▇▇ will notify the Transfer Agent or its designee by 11:00 a.m.
Eastern Time on the next following Business Day.
(b)The Company shall pay for Shares on the same day that it notifies
the Fund of a purchase request for such Shares. Payment for Shares shall be made
in federal funds transmitted to the Fund via the NSCC Fund/SERV DCC&S platform
to be received by the Fund by the close of the Federal Reserve wire system on
the day the Underwriter is notified of the purchase request for Shares (unless
the Underwriter determines and so advises the Company that sufficient proceeds
are available from redemption of Shares of other Designated Portfolios effected
pursuant to redemption requests tendered by the Company on behalf of the
Account). Upon the Fund's receipt of federal funds transmitted via the NSCC
Fund/SERV DCC&S platform, such funds shall cease to be the responsibility of the
Company and shall become the responsibility of the Fund. Notwithstanding any
provision of this Agreement to the contrary, for purchase and redemption
instructions with respect to any Shares, Company and the Fund will settle the
purchase and redemption transactions referred to herein, via the NSCC Fund/SERV
platform settlement process on the next Business Day following the effective
trade date. The Underwriter will provide to Company a daily transmission of
positions and trading activity taking place in the Omnibus Accounts using
Company's affiliate's proprietary Inventory Control System ("ICS").
(c) To the extent practicable, payment for Shares redeemed by the
Account or the Company shall be made in federal funds transmitted via the NSCC
Fund/SERV DCC&S platform to the Company on the next Business Day after the Fund
is properly notified of the redemption order of such Shares (unless redemption
proceeds are to be applied to the purchase of
3
Shares of other Designated Portfolios in accordance with Section 1.3(b) of this
Agreement), except that the Fund reserves the right to redeem Shares in assets
other than cash and to delay payment of redemption proceeds to the extent
permitted under Section 22(e) of the 1940 Act and any Rules thereunder, and in
accordance with the procedures and policies of the Fund as described in the
Prospectus. The Fund shall not bear any responsibility whatsoever for the proper
disbursement or crediting of redemption proceeds by the Company; the Company
alone shall be responsible for such action.
(d) Any purchase or redemption request for Shares held or to be held
in the Company's general account shall be effected at the closing net asset
value per share next determined after the Fund's receipt of such request as set
forth in Section 1.3(a) herein.
1.4. The Underwriter shall use its best efforts to make the closing net
asset value per Share for each Designated Portfolio available to the Company by
6:30 p.m. Eastern Time each Business Day via the NSCC Profile 1 platform, and in
any event, as soon as reasonably practicable after the closing net asset value
per Share for such Designated Portfolio is calculated, and shall calculate such
closing net asset value, including any applicable daily dividend factor, in
accordance with the Prospectus. In the event the Underwriter is unable to make
the 6:30 p.m. deadline stated herein, it shall provide additional time for the
Company to place orders for the purchase and redemption of Shares. Such
additional time shall be equal to the additional time that the Fund takes to
make the closing net asset value available to the Company. Neither the Fund,
[any Designated Portfolio], the Underwriter, nor any of their affiliates shall
be liable for any information provided to the Company pursuant to this Agreement
which information is based on incorrect information supplied by the Company to
the Fund or the Underwriter. Any material error in the calculation or reporting
of the closing net asset value, including any applicable daily dividend factor
per Share shall be reported promptly upon discovery to the Company. The
determination of the materiality of any net asset value pricing error shall be
based on the Fund's policy for correction of pricing errors. In such event the
Company shall be entitled to an adjustment to the number of Shares purchased or
redeemed to reflect the correct closing net asset value, including any
applicable daily dividend factor per Share and the Fund or its affiliate shall
bear the cost of correcting such errors in the Omnibus Accounts. Any error of a
lesser amount shall be corrected in the next business day's net asset value per
Share.
1.5. Notwithstanding anything to the contrary contained in this Agreement,
the Fund will make available for purchase by the Company, on its behalf and on
behalf of the Account a class of shares available at net asset value which are
not subject to a contingent deferred sales charge. In addition, no exchange fees
will be applicable to shares of the Funds purchased by the Company, on its
behalf and on behalf of the Account. The Fund shall furnish notice (via the NSCC
Profile II platform) to the Company as soon as reasonably practicable of any
income dividends or capital gain distributions payable on any Shares. The form
of payment of dividends and capital gains distributions will be determined in
accordance with the Company's operational procedures in effect at the time of
the payment of such dividend or distribution. At this time the Company, on its
behalf and on behalf of the Account, hereby elects to receive all such dividends
4
and distributions as are payable on any Shares in the form of additional Shares
of that [Designated Portfolio]. Company will reinvest the additional Shares of
that [Designated Fund] through a trade processed via the NSCC platform. The
Company reserves the right, on its behalf and on behalf of the Account, to
revoke this election and to receive all such dividends and capital gain
distributions in the form of cash. The parties understand and agree that all
transactions of Account shares contemplated herein shall be executed through the
Omnibus Account and that Company's affiliate, ▇▇▇▇▇▇▇ Lynch, Pierce, ▇▇▇▇▇▇ &
▇▇▇▇▇, Inc. will receive all such dividends and distributions in the form of
cash which Company, in turn, will immediately reinvest in the form of additional
Shares of that Designated Portfolio. The Transfer Agent shall notify the Company
promptly of the number of Shares so issued as payment of such dividends and
distributions.
1.6. Issuance and transfer of Shares shall be by book entry only and
executed through the Omnibus Accounts. Stock certificates will not be issued to
the Company or the Account. Purchase and redemption orders for Fund shares shall
be recorded in an appropriate ledger for the Account or the appropriate
subaccount of the Account.
1.7 Fund Information.
(a) The Underwriter will provide (or cause to be provided) to Company the
information set forth in Schedule C hereto. In addition, notwithstanding
anything contained in this Agreement to the contrary, the Fund hereby agrees
that Company may use such information in communications prepared for the
Contracts, including, but not limited to, application, marketing, sales and
other communications materials reviewed and approved by the Underwriter or the
Fund in accordance with Section 4.1. The Fund will provide timely notification
to Company of any change to the information described in Part I of Schedule C
including without limitation any change to the CUSIP number or symbol
designation of a Fund. Such notification shall be given to Company at least ten
(10) Business Days prior to the effective date of the change or the effect of
the change with respect to transactions by the Account in any affected Fund
shall be delayed for a reasonable time following notification hereunder. The
information requested in Schedule C, Part I - performance, holdings etc. -
cannot be given ahead of time
(b) Notwithstanding anything to the contrary in this Agreement, upon
request, the Underwriter will provide Company with prospectuses, proxy
materials, financial statements, reports and other materials relating to each
Fund in sufficient quantity for each Contract owner invested in the Fund.
(c) With the exception of (i) listings of product offerings; (ii)
materials in the public domain (e.g., magazine articles and trade publications);
and (iii) materials used by on an internal basis only, Company agrees not to
furnish or cause to be furnished to any third parties or to display publicly or
publish any information or materials relating to the Funds, except such
materials and information as may be distributed to Company by the Underwriter or
approved for distribution by Fund or the Underwriter upon Company's request.
5
1.8. The parties hereto acknowledge that the arrangement contemplated by
this Agreement is not exclusive; the Fund's shares may be sold to other
investors and the cash value of the Contracts may be invested in other
investment companies. The Company acknowledges that shares of the Fund are
offered and sold directly to members of the general public, and are not and will
not be sold directly to insurance companies and their separate accounts and
certain qualified retirement plus in accordance with Section 817 (h)(4) of the
Internal Revenue Code of 1986, as amended, and Treasury Regulation 1.817-5.
1.9 Contract Owner Information (This section will be effective as of
October 16, 2006)
(a) Agreement to Provide Information. Insurance Company agrees to provide
the Fund, upon written request, the taxpayer identification number ("TIN"), if
known, of any or all Contract owner(s) and the amount, date, name or other
identifier of any investment professional(s) associated with the Contract
owner(s) (if known), and transaction type (purchase, redemption, transfer, or
exchange) of every purchase, redemption, transfer, or exchange of Shares held
through a Company Fund Account during the period covered by the request.
(i) Period Covered by Request. Requests must set forth a specific
period, not to exceed one year from the date of the request,
for which transaction information is sought. A request may be
ongoing and continuous (e.g., for each trading day throughout
the year) or for specified periods of time. The Fund may
request transaction information older than one year from the
date of the request as it deems necessary to investigate
compliance with policies established by the Fund for the
purpose of eliminating or reducing market timing and abusive
trading practices.
(ii) Form and Timing of Response. Company agrees to transmit the
requested information that is on its books and records to the
Fund or its designee promptly, but in any event not later than
ten business days, after receipt of a request. If the
requested information is not on Company's books and records,
Company agrees to use reasonable efforts to: (i) promptly
obtain and transmit the requested information; (ii) obtain
assurances from the accountholder that the requested
information will be provided directly to the Fund promptly; or
(iii) if directed by the Fund, block further purchases of
Shares from such accountholder. In such instance, Company
agrees to inform the Fund whether it plans to perform (i),
(ii) or, at the direction of the Fund, (iii). Responses
required by this Section 1.9 must be communicated in writing
and in a format mutually agreed upon by the parties. To the
extent practicable, the format for any transaction information
provided to the Fund should be consistent with the NSCC
Standardized Data Reporting Format.
6
(iii) Limitations on Use of Information. The Fund agrees not to use
the Contract owner information received from Company pursuant
to this Agreement for marketing or any other similar purpose
without the prior written consent of Company.
(b) Agreement to Restrict Trading. Company agrees to execute written
instructions from the Fund to restrict or prohibit further purchases or
exchanges of Shares by a Contract owner that has been identified by the Fund as
having engaged in transactions in Shares through a Company Fund Account that
violate policies established for the purpose of eliminating or reducing market
timing and abusive trading practices.
(i) Form of Instructions. Instructions must include the TIN, if
known, and the specific restriction(s) to be executed. If the
TIN is not known, the instructions must include an equivalent
identifying number of the Contract owner(s) or the Company
Fund Account(s) or other agreed upon information to which the
instruction relates.
(ii) Timing of Response. Company agrees to execute instructions as
soon as reasonably practicable, but not later than five
business days after receipt of the instructions by the
Company.
(iii) Confirmation by Company. Company must provide written
confirmation to the Fund that instructions have been executed.
Company agrees to provide confirmation as soon as reasonably
practicable, but not later than ten business days after the
instructions have been executed.
(c) Definitions. For purposes of this Section 1.9:
(i) The term "Company Fund Account" means an Omnibus Account with
the Fund maintained by Company.
(ii) The term "Fund" includes the Underwriter, the Fund's transfer
agent and the Designated Portfolios.
(iii) The term "Shares" means the interests of Contract owners
corresponding to the redeemable securities of record issued by
the Fund under the Investment Company Act of 1940 that are
held by or through a Company Fund Account.
(iv) The term "Contract owner" means the holder of interests in a
variable annuity or variable life insurance contract issued by
Company owning Shares held by or through a Company Fund
Account.
7
(v) The term "written" and/or "in writing" includes electronic
writings and facsimile transmissions.
ARTICLE II. Representations and Warranties
2.1. The Company represents and warrants that the Contracts (a) are, or
prior to issuance will be, registered under the 1933 Act, or (b) are not
registered because they are properly exempt from registration under the 1933 Act
or will be offered exclusively in transactions that are properly exempt from
registration under the 1933 Act. The Company further represents and warrants
that the Contracts will be issued and sold in compliance in all material
respects with all applicable federal securities and state securities and
insurance laws and that the sale of the Contracts shall comply in all material
respects with state insurance suitability requirements. The Company further
represents and warrants that it is an insurance company duly organized and in
good standing under applicable law, that it has legally and validly established
the Account prior to any issuance or sale thereof as a segregated asset account
under Arkansas insurance laws, and that it (a) has registered or, prior to any
issuance or sale of the Contracts, will register the Account as a unit
investment trust in accordance with the provisions of the 1940 Act to serve as a
segregated investment account for the Contracts, or alternatively (b) has not
registered the Account in proper reliance upon an exclusion from registration
under the 1940 Act. The Company shall register and qualify the Contracts or
interests therein as securities in accordance with the laws of the various
states only if and to the extent deemed advisable by the Company.
2.2. The Fund represents and warrants that Shares sold pursuant to this
Agreement shall be registered under the 1933 Act and, duly authorized for
issuance and sold in compliance with applicable state and federal securities
laws. and that the Fund is and shall remain registered under the ▇▇▇▇ ▇▇▇. The
Fund shall amend the registration statement for its shares under the 1933 Act
and the 1940 Act from time to time as required in order to effect the continuous
offering of its shares. The Fund shall register and qualify the shares for sale
in accordance with the laws of the various states only if and to the extent
deemed advisable by the Fund, the Adviser, or the Underwriter.
2.3. The Fund and the Underwriter agree to comply in all material respects
with any applicable state insurance laws or regulations (including the
furnishing of information not otherwise available to the Company which is
required by state insurance law to enable the Company to obtain the authority
needed to issue the Contracts in any applicable state, and including cooperating
with the Company in any filings of sales literature for the Contracts), to the
extent notified thereof in writing by the Company; provided that such compliance
(i) is not inconsistent with any other laws or regulations applicable to the
Fund or the Underwriter; (ii) is consistent with the Designated Portfolio's
objectives, policies and permissible investment
8
transactions; and (iii) is, in the sole discretion of the Board, in the best
interests of the shareholders of such Designated Portfolio.
2.4. The Funds represent that they are lawfully organized and validly
existing under the laws of the states shown on Schedule B and that each does and
will comply in all material respects with the 1940 Act.
2.6. The Underwriter represents and warrants that it is a member in good
standing of the NASD and is registered as a broker-dealer with the SEC. The
Underwriter further represents that it will sell and distribute the Fund shares
in compliance with all material respects with any applicable state and federal
securities laws.
2.7. The Fund represents and warrants that all of its trustees/directors,
officers, employees, investment advisers, and other individuals or entities
dealing with the money and/or securities of the Fund are and shall continue to
be at all times covered by a blanket fidelity bond or similar coverage for the
benefit of the Fund in an amount not less than the minimum coverage as required
currently by Rule 17g-1 of the 1940 Act or related provisions as may be
promulgated from time to time. The aforesaid bond shall include coverage for
larceny and embezzlement and shall be issued by a reputable bonding company.
2.8 The Company represents and warrants that it will offer and sell Shares
only in accordance with the terms and conditions of the Prospectus and statement
of additional information (the "SAI") and in compliance in all material respects
with any applicable state and federal securities laws.
2.9 The Company represents and warrants that it
(i) has adopted and implemented and will monitor, on a continuous basis,
its compliance with procedures reasonably designed to prevent violations of
relevant law, regulation and Prospectus requirements with respect to late
trading, market timing and abusive trading practices;
(ii) will provide information and further certification to the Underwriter
or its designee to verify compliance with this Section 2.9; and
(iii) will cooperate in monitoring and enforcing the Fund's market timing,
late trading, and any redemption fee policies as set forth in the Prospectus and
such other policies established by the Fund from time to time.
ARTICLE III. Prospectuses and Proxy Statements; Voting
3.1. The Underwriter shall provide the Company with as many copies of the
Fund's current prospectus as the Company may reasonably request. The Fund
or the Underwriter
9
shall bear the expense of setting in type and printing copies of the
current prospectus and profiles for the Fund that will be distributed to
existing Contract owners whose contracts are funded by the Fund's shares,
and the Company shall bear the expense of setting in type and printing
copies of the Fund's prospectus and profiles that are used in connection
with offering the Contracts issued by the Company. If requested by the
Company in lieu thereof, the Fund shall provide such documentation
(including a final copy of the new prospectus on diskette at the Fund's or
Underwriter's expense) and other assistance as is reasonably necessary in
order for the Company once each year (or more frequently if the prospectus
for the Fund is amended) to have the prospectus for the Contracts and the
Fund's prospectus printed together in one document. If the Company chooses
to receive camera-ready film or diskettes in lieu of receiving printed
copies of the Prospectus and/or SAI, the Fund shall bear the cost of
typesetting to provide the Prospectus and/or SAI to the Company in the
format in which the Fund is accustomed to formatting prospectuses and
statements of additional information, respectively, and the Company shall
bear the expense of adjusting or changing the format to conform with any
of its prospectuses and/or statements of additional information. In such
event, the Fund will reimburse the Company in an amount equal to the
product of x and y where x is the number of such prospectuses distributed
to Contract owners, and y is the Fund's per unit cost of printing the
Fund's prospectuses. The same procedures shall be followed with respect to
the SAI. The Fund shall not pay any costs of typesetting or printing the
Prospectus and/or SAI to prospective Contract owners.
3.2. The Fund's prospectus shall state that the current SAI for the Fund
is available, and the Underwriter (or the Fund), at its expense, shall provide a
reasonable number of copies of such SAI free of charge to the Company for itself
and for any owner of a Contract who requests such SAI.
3.3. Upon the reasonable request of the Company, the Underwriter shall
provide the Company with information regarding the Fund's expenses from its
annual or semi-annual reports, which information may include a table of fees and
related narrative disclosure for use in any prospectus or other descriptive
document relating to a Contract.
3.4. The Underwriter, at its or the Fund's expense, shall provide the
Company with copies of its proxy material, reports to shareholders, and other
communications to shareholders in such quantity as the Company shall reasonably
require for distributing to Contract owners.
3.5. The Company shall:
(i) solicit voting instructions from Contract owners;
(ii) vote the Shares in accordance with instructions received from
Contract owners; and
10
(iii) vote Shares for which no instructions have been received in
the same proportion as Shares of such portfolio for which
instructions have been received,
so long as and to the extent that the SEC continues to interpret the 1940 Act to
require pass-through voting privileges for variable contract owners or to the
extent otherwise required by law. The Company will vote Shares held in any
segregated asset account for its own account in the same proportion as Shares of
such portfolio for which voting instructions have been received from Contract
owners, to the extent permitted by law.
ARTICLE IV. Sales Material and Information
4.1. The Company shall furnish, or shall cause to be furnished, to the
Fund, the Underwriter, or their designees, each piece of sales literature or
other promotional material that the Company develops and in which the Fund [(or
a Designated Portfolio thereof)] or the Adviser or the Underwriter is named. No
such material shall be used until approved by the Fund, the Underwriter or their
designees. The Fund, the Underwriter, or their designees will be deemed to have
approved such sales literature or promotional material unless the Fund, the
Underwriter or their designees object or provide comments to the Company within
ten (10) Business Days after receipt of such material. The Fund, the
Underwriter, or their designees reserve the right to reasonably object to the
continued use of any such sales literature or other promotional material in
which the Fund [(or a Designated Portfolio thereof)] or the Adviser or the
Underwriter is named, and no such material shall be used if the Fund, the
Underwriter or their designees so object.
4.2. The Company shall not give any information or make any
representations or statements on behalf of the Fund or concerning the Fund or
the Adviser or the Underwriter in connection with the sale of the Contracts
other than the information or representations contained in the registration
statement or profiles or prospectus or SAI for the Fund shares, as such
registration statement and profiles and prospectus or SAI may be amended or
supplemented from time to time, or in reports or proxy statements for the Fund,
or in sales literature or other promotional material approved by the Fund or its
designee or by the Underwriter, except with the permission of the Fund or the
Underwriter or the designee of either.
4.3. The Underwriter, or its designee, shall furnish, or cause to be
furnished, to the Company, each piece of sales literature or other promotional
material that it develops and in which the Company, and/or its Account, is
named. No such material shall be used until approved by the Company. The Company
will be deemed to have approved such sales literature or promotional material
unless the Company objects or provides comments to the Fund, the Underwriter, or
their designee within ten Business Days after receipt of such material. The
Company reserves the right to reasonably object to the continued use of any such
sales literature or other promotional material in which the Company and/or its
Account is named, and no such material shall be used if the Company so objects.
11
4.4. The-Underwriter shall not give any information or make any
representations on behalf of the Company or concerning the Company, the Account,
or the Contracts other than the information or representations contained in a
registration statement and prospectus (which shall include an offering
memorandum, if any, if the Contracts issued by the Company or interests therein
are not registered under the 1933 Act), or SAI for the Contracts, as such
registration statement, prospectus, or SAI may be amended or supplemented from
time to time, or in published reports for the Account which are in the public
domain or approved by the Company for distribution to Contract owners, or in
sales literature or other promotional material approved by the Company or its
designee, except with the permission of the Company.
4.5. The Underwriter will provide to the Company at least one complete
copy of all registration statements, profiles, prospectuses, SAIs, shareholder
reports, proxy statements, sales literature and other promotional materials, and
upon request, applications for exemptions, requests for no-action letters, and
all amendments to any of the above, that relate to the Fund or its shares,
promptly after the filing of such document(s) with the SEC or other regulatory
authorities.
4.6. The Company will provide to the Fund or the Underwriter at least one
complete copy of all registration statements, prospectuses (which shall include
an offering memorandum, if any, if the Contracts issued by the Company or
interests therein are not registered under the 1933 Act), SAIs, reports,
solicitations for voting instructions, sales literature and other promotional
materials, applications for exemptions, requests for no-action letters, and all
amendments to any of the above, that relate to the Contracts or the Account,
promptly after the filing of such document(s) with the SEC or other regulatory
authorities. The Company shall provide to the Fund and the Underwriter any
complaints received from the Contract owners pertaining to the Fund [or the
Designated Portfolio].
4.7. The Underwriter will provide the Company with as much notice as is
reasonably practicable of any proxy solicitation [for any Designated Portfolio],
and, if possible, of any material change in the Fund's registration statement,
particularly any change resulting in a change to the registration statement or
prospectus for any Account. The Fund will work with the Company so as to enable
the Company to solicit proxies from Contract owners, or to make changes to its
prospectus or registration statement, in an orderly manner.
4.8. For purposes of this Article IV, the phrase "sales literature and
other promotional materials" includes, but is not limited to, any of the
following that refer to the Fund or any affiliate of the Fund: advertisements
(such as material published, or designed for use in, a newspaper, magazine, or
other periodical, radio, television, telephone or tape recording, videotape
display, signs or billboards, motion pictures, or other public media), sales
literature (i.e., any written communication distributed or made generally
available to customers or the public, including brochures, circulars, reports,
market letters, form letters, seminar texts, reprints or excerpts of any other
advertisement, sales literature, or published article), educational or
12
training materials or other communications distributed or made generally
available to some or all agents or employees, and registration statements,
prospectuses, SAIs, shareholder reports, proxy materials, and any other
communications distributed or made generally available with regard to the Fund.
ARTICLE V. Fees and Expenses
5.1. All expenses incident to performance by the Fund or the Underwriter
under this Agreement shall be paid by the Fund or the Underwriter as
appropriate. The Fund shall see to it that all its shares are registered and
authorized for issuance in accordance with applicable federal law and, if and to
the extent deemed advisable by the Fund or the Underwriter, in accordance with
applicable state laws prior to their sale. The Fund shall bear the expenses for
the cost of registration and qualification of the Fund's shares, preparation and
filing of the Fund's prospectus and registration statement, proxy materials and
reports, setting in type and printing the proxy materials and reports to
shareholders (including the costs of printing a prospectus that constitutes an
annual report), the preparation of all statements and notices required by any
federal or state law, and all taxes on the issuance or transfer of the Fund's
shares and, as set forth in Section 3.1, setting the Fund's prospectus in type.
5.2. The Company shall bear the expenses of distributing the Fund's
prospectus to owners of Contracts in connection with the offer of Contracts,
issued by the Company and of distributing the Fund's proxy materials and reports
to such Contract owners.
ARTICLE VI. Qualification under Subchapter M
6.1. The Fund represents that it is or will be qualified as a Regulated
Investment Company under Subchapter M of the Code, and that it will use its best
efforts to maintain such qualification (under Subchapter M or any successor or
similar provisions) and that it will notify the Company immediately upon having
a reasonable basis for believing that it has ceased to so qualify or that it
might not so qualify in the future.
13
ARTICLE VII. Indemnification
7.1. Indemnification By the Company
7.1(a). The Company agrees to indemnify and hold harmless the Fund
and the Underwriter and each of its trustees/directors and officers, and each
person, if any, who controls the Fund or the Underwriter within the meaning of
Section 15 of the 1933 Act or who is under common control with the Underwriter
(collectively, the "Indemnified Parties" for purposes of this Section 7.1)
against any and all losses, claims, damages, liabilities (including amounts paid
in settlement with the written consent of the Company) or litigation (including
legal and other expenses), to which the Indemnified Parties may become subject
under any statute or regulation, at common law or otherwise, insofar as such
losses, claims, damages, liabilities or expenses (or actions in respect thereof)
or settlements:
(i) arise out of or are based upon any untrue statement or alleged
untrue statements of any material fact contained in the registration
statement, prospectus (which shall include a written description of
a Contract that is not registered under the 1933 Act), or SAI for
the Contracts or contained in sales literature for the Contracts (or
any amendment or supplement to any of the foregoing), or arise out
of or are based upon the omission or the alleged omission to state
therein a material fact required to be stated therein or necessary
to make the statements therein not misleading, provided that this
agreement to indemnify shall not apply as to any Indemnified Party
if such statement or omission or such alleged statement or omission
was made in reliance upon and in conformity with information
furnished to the Company by or on behalf of the Fund for use in the
registration statement, prospectus or SAI for the Contracts or in
the Contracts or sales literature (or any amendment or supplement)
or otherwise for use in connection with the sale of the Contracts or
Fund shares; or
(ii) arise out of or as a result of statements or representations
(other than statements or representations contained in the
registration statement, prospectus, SAI, or sales literature of the
Fund not supplied by the Company or persons under its control) or
wrongful conduct of the Company or its agents or persons under the
Company's authorization or control, with respect to the sale or
distribution of the Contracts or Fund Shares; or
(iii) arise out of any untrue statement or alleged untrue statement
of a material fact contained in a registration statement,
prospectus, SAI, or sales literature of the Fund or any amendment
thereof or supplement thereto or the omission or alleged omission to
state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading if such a
statement or omission was made in reliance upon information
furnished to the Fund by or on behalf of the Company; or
14
(iv) arise out of any willful misconduct or gross negligence (as
measured by industry standards) of Company, its agents and
employees, in the performance of, or failure to perform, its
obligations under this Agreement, or any reckless disregard of its
obligations under this Agreement; or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Company in this Agreement
or arise out of or result from any other material breach of this
Agreement by the Company;
as limited by and in accordance with the provisions of Sections 7.1(b) and
7.1(c) hereof.
7.1(b). The Company shall not be liable under this indemnification
provision with respect to any losses, claims, damages, liabilities or
litigation to which an Indemnified Party would otherwise be subject by
reason of such Indemnified Party's willful misfeasance, bad faith, or
gross negligence in the performance of such Indemnified Party's duties or
by reason of such Indemnified Party's reckless disregard of its
obligations or duties under this Agreement.
7.1(c). The Company shall not be liable under this indemnification
provision with respect to any claim made against an Indemnified Party
unless such Indemnified Party shall have notified the Company in writing
within a reasonable time after the summons or other first legal process
giving information of the nature of the claim shall have been served upon
such Indemnified Party (or after such Indemnified Party shall have
received notice of such service on any designated agent), but failure to
notify the Company of any such claim shall not relieve the Company from
any liability which it may have to the Indemnified Party against whom such
action is brought otherwise than on account of this indemnification
provision. In case any such action is brought against an Indemnified
Party, the Company shall be entitled to participate, at its own expense,
in the defense of such action. The Company also shall be entitled to
assume the defense thereof, with counsel satisfactory to the party named
in the action. After notice from the Company to such party of the
Company's election to assume the defense thereof, the Indemnified Party
shall bear the fees and expenses of any additional counsel retained by it,
and the Company will not be liable to such party under this Agreement for
any legal or other expenses subsequently incurred by such party
independently in connection with the defense thereof other than reasonable
costs of investigation.. The Company, in the defense of any such claim or
litigation, shall not , without the written consent of the Indemnified
Party, consent to entry of any judgment or enter into any settlement.
7.1(d). The Indemnified Parties will promptly notify the Company of
the commencement of any litigation or proceedings against them in
connection with the issuance or sale of the Fund shares or the Contracts
or the operation of the Fund.
15
7.1(e) The Company shall not be liable for special, consequential or
incidental damages. This indemnity agreement will be in addition to any
liability, which the Company may otherwise have.
7.2. Indemnification by the Underwriter
7.2(a). The Underwriter agrees to indemnify and hold harmless the
Company and each of its directors and officers and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act
(collectively, the "Indemnified Parties" for purposes of this Section 7.2)
against any and all losses, claims, damages, liabilities (including amounts paid
in settlement with the written consent of the Underwriter) or litigation
(including legal and other expenses) to which the Indemnified Parties may become
subject under any statute or regulation, at common law or otherwise, insofar as
such losses, claims, damages, liabilities or expenses (or actions in respect
thereof) or settlements:
(i) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in the registration
statement or profile or prospectus or SAI or sales literature of the
Fund (or any amendment or supplement to any of the foregoing), or
arise out of or are based upon the omission or the alleged omission
to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, provided
that this agreement to indemnify shall not apply as to any
Indemnified Party if such statement or omission or such alleged
statement or omission was made in reliance upon and in conformity
with information furnished to the Underwriter or the Fund by or on
behalf of the Company for use in the registration statement,
profile, prospectus or SAI for the Fund or in sales literature (or
any amendment or supplement) or otherwise for use in connection with
the sale of the Contracts or Fund shares; or
(ii) arise out of or as a result of statements or representations
(other than statements or representations contained in the
registration statement, prospectus, SAI or sales literature for the
Contracts not supplied by the Underwriter or persons under their
control) or wrongful conduct of the Fund or the Underwriter or
persons under their control, with respect to the sale or
distribution of the Contracts or Fund shares; or
(iii) arise out of any untrue statement or alleged untrue statement
of a material fact contained in a registration statement,
prospectus, SAI or sales literature covering the Contracts, or any
amendment thereof or supplement thereto, or the omission or alleged
omission to state therein a material fact required to be stated
therein or necessary to make the statement or statements therein not
misleading, if such statement or omission was made in reliance upon
information furnished to the Company by or on behalf of the Fund or
the Underwriter; or
16
(iv) arise out of any willful misconduct or gross negligence (as
measured by industry standards) of the Fund or the Underwriter, its
agents and employees, in the performance of, or failure to perform,
its obligations under this Agreement, or any reckless disregard of
its obligations under this Agreement; or
(v) arise out of or result from any material breach of any
representation and/or warranty made by the Fund or the Underwriter
in this Agreement or arise out of or result from any other material
breach of this Agreement by the Fund or the Underwriter.
as limited by and in accordance with the provisions of Sections 7.2(b) and
7.2(c) hereof.
7.2(b). The Underwriter shall not be liable under this
indemnification provision with respect to any losses, claims, damages,
liabilities or litigation to which an Indemnified Party would otherwise be
subject by reason of such Indemnified Party's willful misfeasance, bad faith, or
gross negligence in the performance or such Indemnified Party's duties or by
reason of such Indemnified Party's reckless disregard of obligations and duties
under this Agreement or to the Company or the Account, whichever is applicable.
7.2(c). The Underwriter shall not be liable under this
indemnification provision with respect to any claim made against an Indemnified
Party unless such Indemnified Party shall have notified the Underwriter in
writing within a reasonable time after the summons or other first legal process
giving information of the nature of the claim shall have been served upon such
Indemnified Party (or after such Indemnified Party shall have received notice of
such service on any designated agent), but failure to notify the Underwriter of
any such claim shall not relieve the Underwriter from any liability which it may
have to the Indemnified Party against whom such action is brought otherwise than
on account of this indemnification provision. In case any such action is brought
against the Indemnified Party, the Underwriter will be entitled to participate,
at its own expense, in the defense thereof. The Underwriter also shall be
entitled to assume the defense thereof, with counsel satisfactory to the party
named in the action. After notice from the Underwriter to such party of the
Underwriter's election to assume the defense thereof, the Indemnified Party
shall bear the fees and expenses of any additional counsel retained by it, and
the Underwriter will not be liable to such party under this Agreement for any
legal or other expenses subsequently incurred by such party independently in
connection with the defense thereof other than reasonable costs of
investigation. The Underwriter, in the defense of any such claim or litigation,
shall not , without the written consent of the Indemnified Party, consent to
entry of any judgment or enter into any settlement.
7.2(d). The Indemnified Party will promptly notify the Underwriter
of the commencement of any litigation or proceedings against it or any of its
officers or directors in connection with the issuance or sale of the Contracts
or the operation of the Account.
17
7.2(e) The Underwriter shall not be liable for special,
consequential or incidental damages. This indemnity agreement will be in
addition to any liability, which the Underwriter may otherwise have.
ARTICLE VIII. Applicable Law
8.1. This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of the State of New York.
8.2. This Agreement shall be subject to the provisions of the 1933, 1934,
and 1940 Acts, and the rules and regulations and rulings thereunder, including
such exemptions from those statutes, rules, and regulations as the SEC may grant
and the terms hereof shall be interpreted and construed in accordance therewith.
ARTICLE IX. Termination
9.1. This Agreement shall continue in full force and effect until the
first to occur of:
(a) termination by any party, for any reason with respect to some
or all [Designated Portfolios], by three (3) months advance
written notice delivered to the other parties; or
(b) termination by the Company by written notice to the Fund and
the Underwriter based upon the Company's determination that
shares of the Fund are not reasonably available to meet the
requirements of the Contracts; or
(c) termination by the Company by written notice to the Fund and
the Underwriter in the event any of the Shares are not
registered, issued, or sold in accordance with applicable
state and/or federal law or such law precludes the use of such
Shares as the underlying investment media of the Contracts
issued or to be issued by the Company; or
(d) termination by the Fund or the Underwriter in the event that
formal administrative proceedings are instituted against the
Company by the NASD, the SEC, the Insurance Commissioner, or
like official of any state or any other regulatory body
regarding the Company's duties under this Agreement or related
to the sale of the Contracts, the operation of any Account, or
the purchase of the Shares; provided, however, that the Fund
or the Underwriter determines in its sole judgment exercised
in good faith, that any such administrative proceedings will
have a material adverse
18
effect upon the ability of the Company to perform its
obligations under this Agreement; or
(e) termination by the Company in the event that formal
administrative proceedings are instituted against the Fund or
the Underwriter by the NASD, the SEC, or any state securities
or insurance department, or any other regulatory body;
provided, however, that the Company determines in its sole
judgment exercised in good faith, that any such administrative
proceedings will have a material adverse effect upon the
ability of the Fund or the Underwriter to perform its
obligations under this Agreement; or
(f) termination by the Company by written notice to the Fund and
the Underwriter with respect to any Designated Portfolio in
the event that such Portfolio ceases to qualify as a Regulated
Investment Company under Subchapter M as specified in Section
6.1 hereof, or if the Company reasonably believes that such
Portfolio may fail to so qualify or comply; or
(g) termination by the Fund or the Underwriter by written notice
to the Company, if the Fund or the Underwriter respectively,
shall determine, in their sole judgment exercised in good
faith, that the Company has suffered a material adverse change
in its business, operations, financial condition, or prospects
since the date of this Agreement or is the subject of material
adverse publicity; or
(h) termination by the Company by written notice to the Fund and
the Underwriter, if the Company shall determine, in its sole
judgment exercised in good faith, that the Fund, the Adviser,
or the Underwriter has suffered a material adverse change in
its business, operations, financial condition, or prospects
since the date of this Agreement or is the subject of material
adverse publicity; or
(i) termination by the Company upon any substitution of the shares
of another investment company or series thereof for Shares in
accordance with the terms of the Contracts, provided that the
Company has given at least 45 days prior written notice to the
Fund and the Underwriter of the date of substitution; or
(j) transaction by any party upon another party's failure to cure
a material breech of any provision of this Agreement within 30
days after written notice thereof.
19
9.2. (a) Notwithstanding any termination of this Agreement, the Fund and
the Underwriter shall, at the option of the Company, continue to
make available additional Shares pursuant to the terms and
conditions of this Agreement, for all Contracts in effect on the
effective date of termination of this Agreement (hereinafter
referred to as "Existing Contracts"), provided the Company continues
to pay the costs set forth in Section 3.1 and 5.2 and unless such
further sale of Shares is proscribed by law, regulation or
applicable regulatory body, or unless the Fund determines that
liquidation of the Designated Portfolio following termination of
this Agreement is in the best interests of the Designated Portfolio
and its shareholders. Specifically, the owners of the Existing
Contracts may be permitted to reallocate investments in the Fund,
redeem investments in the Fund, and/or invest in the Fund upon the
making of additional purchase payments under the existing Contracts
(subject to any such election by the Underwriter). The parties agree
that this Section 9.2 shall not apply to any terminations under
Section 9.1(i) of this Agreement.
(b) In the event of a termination of this agreement pursuant to Section
9.1 ( other than 9.1(i)), the Company shall promptly notify the Fund
and the Underwriter whether the Fund and the Underwriter will be
required to continue to make shares available after such
termination; in such circumstances, the provisions of this Agreement
shall remain in effect except for Section 9.1 hereof, and thereafter
any party may terminate the Agreement ( the "Final Termination"), as
so continued pursuant this Section 9.2,upon prior written notice to
the other parties, such notice to be for a period this reasonable
under the circumstances but, if given by the Fund or the
Underwriter, need not be greater than six months.
(c) The Company, the Fund and the Underwriter agree to cooperate in
respect of the measures that are necessary or appropriate to effect
the Final Termination of this Agreement, and will give reasonable
assistance to each other in that regard, including steps necessary
or appropriate to ensure that an Account owns no shares of the Fund
after the Final Termination of this Agreement.
9.3 The Company shall not redeem Shares attributable to the Contracts (as
opposed to Shares attributable to the Company's assets held in the Account)
except (i) as necessary to implement Contract owner initiated or approved
transactions, (ii) as required by state and/or federal laws or regulations or
judicial or other legal precedent of general application (hereinafter referred
to as a "Legally Required Redemption"), (iii) upon 45 days prior written notice
to the Fund and Underwriter, as permitted by an order of the SEC pursuant to
Section 26(c) of the 1940 Act, but only if a substitution of other securities
for the Shares is consistent with the terms of the Contracts, or (iv) as
permitted under the terms of the Contract. Upon request, the Company will
promptly furnish to the Fund and the Underwriter reasonable assurance that any
redemption pursuant to clause (ii) above is a Legally Required Redemption.
Furthermore, except in cases where permitted under the terms of the Contacts,
the Company shall not prevent Contract owners
20
from allocating payments to a Portfolio that was otherwise available under the
Contracts without first giving the Fund or the Underwriter 45 days notice of its
intention to do so.
9.4. Notwithstanding any termination of this Agreement, each party's
obligation under Article VII to indemnify the other parties and the Company's
obligation under Section 3.5 regarding pass-through and voting shall survive.
ARTICLE X. Notices
Any notice shall be sufficiently given when sent by registered or
certified mail to the other party at the address of such party set forth below
or at such other address as such party may from time to time specify in writing
to the other party.
If to the Fund:
Attn:
If to the Company:
Attn:
If to the Underwriter:
Attn:
ARTICLE XI. Miscellaneous
11.1. All persons dealing with the Fund must look solely to the property
of the Fund, and in the case of a series company, the respective Designated
Portfolios listed on Schedule B hereto as though each such Designated Portfolio
had separately contracted with the Company and the Underwriter for the
enforcement of any claims against the Fund. The parties agree that neither the
Board nor any member thereof, officers, agents, or shareholders of the Fund
assume any personal liability or responsibility for obligations entered into by
or on behalf of the Fund.
11.2 The Company represents that it has established an Anti-Money
Laundering Program ("AML Program") that is designed to comply with applicable
U.S. laws, regulations,
21
and guidance, including rules of self-regulatory organizations, relating to the
prevention of money laundering, terrorist financing, and related financial
crimes. Its AML Program includes written policies and procedures regarding the
i) verification of the identity of the Contract owners and the source of the
Contract owners' funds, and ii) reporting of any suspicious transactions in a
Contract owner's account. The Company agrees to cooperate with the Underwriter
to satisfy the Underwriter's AML due diligence policies, which may include
annual AML compliance certifications, periodic AML due diligence reviews and/or
other requests deemed necessary to ensure its compliance with the AML
regulations. The Company will (but only to the extent consistent with applicable
law) take all steps necessary and appropriate to provide the Fund and/or the
Underwriter with any requested information about Contract owners and their Fund
accounts in the event that the Fund and/or the Underwriter shall request such
information due to an inquiry or investigation by any law enforcement,
regulatory, or administrative authority.
11.3 To the extent Shares are purchased by Contract owners through a
defined contribution plan subject to Title I of the Employee Retirement Income
Security Act of 1974, as amended ("ERISA") (a "Plan"), Company represents and
warrants that the arrangements provided for in this Agreement will be disclosed
to the Plans through their representatives and that Company either:
(a) is not a "fiduciary" with respect to the provision of the
services contemplated herein to any Plan(s) as such term is
defined in Section 3(21) of ERISA and Section 4975 of the
Internal Revenue Code of 1986, as amended (the "Code"); or
(b) the provision of the services contemplated herein to any
Plan(s) will not constitute a non-exempt "prohibited
transaction" as such term is defined in Section 406 of ERISA
and Section 4975 of the Code.
11.4. Subject to the requirements of legal process and regulatory
authority, each party hereto shall treat as confidential the names and addresses
of the owners of the Contracts and all information reasonably identified as
confidential in writing by any other party hereto and, except as permitted by
this Agreement, shall not disclose, disseminate or utilize such names and
addresses and other confidential information without the express written consent
of the affected party until such time as such information has come into the
public domain.
11.5. The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
11.6. This Agreement may be executed simultaneously in two or more
counterparts, each of which taken together shall constitute one and the same
instrument.
11.7. If any provision of this Agreement shall be held or made invalid by
a court decision, statute, rule or otherwise, the remainder of the Agreement
shall not be affected thereby.
22
11.8. Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the SEC, the
NASD, and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation
or inquiry relating to this Agreement or the transactions contemplated hereby.
Notwithstanding the generality of the foregoing, each party hereto further
agrees to furnish the Arkansas Insurance Commissioner with any information or
reports in connection with services provided under this Agreement which such
Commissioner may request in order to ascertain whether the variable contract
operations of the Company are being conducted in a manner consistent with the
Arkansas variable annuity laws and regulations and any other applicable law or
regulations. The Company agrees to pay the reasonable costs and expenses
incurred by the Fund or the Underwriter in connection with responding to such a
request.
11.9. The rights, remedies, and obligations contained in this Agreement
are cumulative and are in addition to any and all rights, remedies, and
obligations, at law or in equity, which the parties hereto are entitled to under
state and federal laws.
11.10. This Agreement or any of the rights and obligations hereunder may
not be assigned by any party without the prior written consent of all parties
hereto; provided, however, that the Underwriter may, with advance written notice
to the other parties hereto, assign this Agreement or any rights or obligations
hereunder to any affiliate of, or company under common control with, the
Underwriter if such assignee is duly licensed and registered to perform the
obligations of the Underwriter under this Agreement.
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement
to be executed in its name and on its behalf by its duly authorized
representative and its seal to be hereunder affixed hereto as of the date
specified below.
▇▇▇▇▇▇▇ ▇▇▇▇▇ LIFE INSURANCE COMPANY:
By its authorized officer
By: _______________________________________
Title: ____________________________________
Date:
[FUND]
By its authorized officer
By:
23
Title:
Date:
JPMORGAN DISTRIBUTIONS SERVICES, INC.
By its authorized officer
By:
Title:
Date:
24
SCHEDULE A
SEPARATE ACCOUNTS OF THE COMPANY
Dated: , 200_
▇▇▇▇▇▇▇ ▇▇▇▇▇ Life Variable Annuity Separate Account D.
SCHEDULE B
DESIGNATED PORTFOLIOS AND CLASSES
Dated: , 200_
SCHEDULE C
FUND MATERIALS
PART I. Fund Description
- The Fund will provide to Company or a common service provider
designated by Company within ten (10) days of the end of each month,
the Fund's average annual returns for the 1, 5, and 10 year periods
ending the current month on a Net Asset Value basis.
- The Fund will provide to Company information about the Fund as of
the last day of the previous month or calendar quarter, including
its top ten holdings, portfolio composition, largest sectors and
geographical allocation and a statement of objective in a mutually
acceptable format no sooner than sixteen days after such month end
or calendar quarter end.
PART II. Fund Information and Materials
The Fund will provide to Company the following information and
materials on an as needed basis, as requested by Company:
- A supply of materials relating to the Funds
(prospectuses, quarterly reports and other brochures) to
include with contract application sales, marketing and
communication materials.
- Specific investment performance information that may be
requested that cannot be obtained from the prospectus.
This would include specific calculations on various
performance parameters which must be provided on a
time-sensitive basis (usually within 5 business days).